Skip to content
healthcare.dev

Floxuridine

NDC 63323-145, FLOXURIDINE, injection, powder, lyophilized, for solution, from Fresenius Kabi USA, LLC.

Product NDC
63323-145
Status
Listed
Labeler
Fresenius Kabi USA, LLC
Dosage form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route
INTRA-ARTERIAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA075837
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/63323-145 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • FLOXURIDINE500 mg/5mL

Pharmacologic classes

Antimetabolite [EPC]; Deoxyuridine [CS]

Package NDCNDC-11Package
63323-145-07633230145071 VIAL in 1 CARTON (63323-145-07) / 5 mL in 1 VIAL

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/c8edabc1-67cd-421b-a147-7c1f19f05b8e

Use it

Look up 63323-145 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/63323-145 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 63323-145. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.